title: Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin.
abstract: Vitreomacular traction and vitreomacular traction with macular hole are conditions associated with visual disturbance and decreased visual acuity. Recent studies have demonstrated that ocriplasmin is effective and safe in specific patient groups with vitreomacular traction, and hence is recommended as a treatment option. We present here a case report of a patient treated with intravitreal ocriplasmin associated with severe loss of vision and delayed resolution of vitreomacular traction. This report highlights that it is important for patients to be made fully aware of the risks of intravitreal ocriplasmin and the prognosis for visual improvement.
authors.affiliation: The Western Eye Hospital, Imperial College Healthcare National Health Service Trust, London, United Kingdom ; Barts Health National Health Service Trust, St Bartholomew's Hospital, West Smithfield, London, United Kingdom.
authors.forename: Joanna
authors.initials: J
authors.lastname: DaCosta
authors.affiliation: The Western Eye Hospital, Imperial College Healthcare National Health Service Trust, London, United Kingdom.
authors.forename: Saad
authors.initials: S
authors.lastname: Younis
keywords: macular hole; ocriplasmin; visual loss; vitreoretinal